Additional Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    University of Maryland - Marlene and Stewart Greenebaum Cancer Center
    Baltimore MD. 21201-1544
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Yale New Haven Hospital
    New Haven CT. 06510
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    The University of Alabama at Birmingham
    Birmingham AL. 35294
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Mercy St. Vincent Medical Center
    Toledo OH. 43608-2603
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0503
    New York NY. 10027
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    University of Iowa Hospitals and Clinics
    Iowa City IA. 522242-1009
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    University of Florida (UF) Health Shands Hospital
    Gainesville FL. 32610
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Duke University Medical Center
    Durham NC. 27710
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Northern Westchester Hospital
    Mount Kisco NY. 10549-3417
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0053
    Burlington ON. L7N 3V2
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0469
    Rock Hill SC. 29732-1160
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0465
    Austell GA. 30106-1110
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0045
    Louisville KY. 40207-4652
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0220
    Ocala FL. 34470
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0099
    Sherbrooke QC. J1H 5N4
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    St Francis Sleep Allergy & Lung Institute
    Clearwater FL. 33765
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0079
    Springfield MA. 01199-1002
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0033
    Towson MD. 21204-7700
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0466
    Pittsburgh PA. 15213
    View Details

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    Local Institution - 0102
    Quebec G1V 4G5
    View Details